SEC Form 4 · accession 0001053369-16-000038
ELITE PHARMACEUTICALS INC /NV/ · ELTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Carter Julian Ward
Officer — CFO, Sec., Treas
Period of report
Feb 16, 2016
Accepted (ET)
Feb 18, 2016 · 6:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001053369
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 16, 2016 | A | 122,325 | $0.2452 | A | 1,085,618 | D | |
| Common Stock | holding | — | — | — | 1,355,014 | I | by IRA |
Table II — derivative securities
No Table II lines on this filing.